|Articles|June 1, 2012
- Pharmaceutical Executive-06-01-2012
- Volume 0
- Issue 0
Pharmaceutical Executive Digital Edition - June 2012
2012 Dealmakers Roundtable
Advertisement
Articles in this issue
over 13 years ago
Gamification Grows Upover 13 years ago
Raising the Stakes in CNSover 13 years ago
A Brand Positioning Nightmareover 13 years ago
Europe Responds to Medical Device 'Crisis'over 13 years ago
Marketing: Medical Devices vs. Pharmaover 13 years ago
Innovation and Collaborationover 13 years ago
From the Editor:The Connections GameNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Brent Saunders: Eyeing New Horizons
2
TrumpRX Has a Blind Spot and It Can Redefine Patient Access
3
Lilly’s Retatrutide Displays Positive Topline Results in Successful Phase III Trial
4
FDA Approves Amgen's Uplizna for Generalized Myasthenia Gravis With Positive AChR or MuSK Antibodies
5
